Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease

Alpha-1 antitrypsin (AAT) is a serum protease inhibitor that belongs to the serpin superfamily. Mutations in AAT are associated with α-1 antitrypsin deficiency (AATD), a rare genetic disease with two distinct manifestations: AATD lung disease and AATD liver disease. AATD lung disease is caused by lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Shuling, Booten, Sheri L, Watt, Andrew, Alvarado, Luis, Freier, Susan M, Teckman, Jeffery H, McCaleb, Michael L, Monia, Brett P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091453/
https://www.ncbi.nlm.nih.gov/pubmed/25054094
http://dx.doi.org/10.4161/rdis.28511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091453/
https://www.ncbi.nlm.nih.gov/pubmed/25054094
http://dx.doi.org/10.4161/rdis.28511

Ejemplares similares